Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.56 |
| ▸ | MEN1 | O00255 | 5/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | CCR1 | P32246 | 1/20 | 0.50 |
| ▸ | CCR8 | P51685 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.47 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | MITF | O75030 | 1/20 | 0.45 |
| ▸ | KDM5A | P29375 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3421833 | 0.97 | KMT2A (0.59) | KMT2AMEN1RAB9AALDH1A1MAPT | |
| SCHEMBL23921025 | 0.95 | KMT2A (0.56) | KMT2AMEN1RAB9AALDH1A1MAPT | |
| SCHEMBL12339168 | 0.91 | KMT2A (0.73) | KMT2AMEN1RAB9AALDH1A1MAPT | |
| SCHEMBL12339141 | 0.87 | RAB9A (0.58) | KMT2AMEN1RAB9AALDH1A1MAPT | |
| SCHEMBL28345601 | 0.87 | ACHE (0.54) | KMT2AMEN1RAB9AALDH1A1MAPT | |
| SCHEMBL4402501 | 0.87 | MEN1 (0.47) | KMT2AMEN1RAB9AALDH1A1MAPT | |
| SCHEMBL7963741 | 0.86 | KDM4E (0.67) | KMT2AMEN1RAB9AALDH1A1HPGD | |
| SCHEMBL2614970 | 0.86 | CCR1 (0.65) | KMT2AMEN1RAB9AALDH1A1MAPT | |
| SCHEMBL4402810 | 0.85 | MEN1 (0.46) | KMT2AMEN1RAB9AALDH1A1MAPT | |
| SCHEMBL15460386 | 0.83 | NPC1 (0.49) | KMT2AMEN1RAB9AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8877355-B2 | Monoamine compound, charge-transporting material, and organic electroluminescent device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-11-04 | — | — | US | disclosed |
| US-20130214263-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-08-22 | — | — | US | disclosed |
| US-8427046-B2 | Monoamine compound, charge-transporting material, and organic electroluminescent device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8337999-B2 | Organic electroluminescent device including at least one layer containing an indole derivative | UDC IRELAND LIMITED (IE) | 2012-12-25 | — | — | US | disclosed |
| US-8168307-B2 | Organic compound, charge transport material and organic electroluminescent device | PIONEER CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20100026174-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | FUJIFILM CORPORATION (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20090230846-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | PIONEER CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC25A21, SLCO2A1, OCIAD2 | KMT2A 1162/4885MEN1 1827/4885RAB9A 1941/4885 |
| US-20090230846-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC7A5, SLC18A1, MAOA | KMT2A 982/4885MEN1 2206/4885RAB9A 362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.